(Q44260959)

1 December 2017

The chronic glomerulonephritides of childhood. Part II (2) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A671149

19 July 2022

author name string

McAdams AJ

series ordinal

2

1 reference

1 December 2017

C. D. West

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A671149

19 July 2022

A. J. McAdams

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A671149

19 July 2022

language of work or name

English

0 references

publication date

1 August 1978

1 reference

The Journal of Pediatrics

1 December 2017

1 reference

1 December 2017

93

1 reference

1 December 2017

2

1 reference

1 December 2017

167-176

1 reference

Extramembranous glomerulonephritis in children: report of 50 cases.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Idiopathic membranous nephropathy in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Extramembranous glomerulonephritis in childhood: Relationship to systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Treatment of idiopathic membranous nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Controlled trial of cyclophosphamide in idiopathic membranous nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Membranoproliferative glomerulonephritis and persistent hypocomplementaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

A "silent" phase of hypocomplementemic persistent nephritis detectable by reduced serum beta-1c-globulin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

The Complement Abnormalities of Lipodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

The C3 nephritic factor and membranoproliferative nephritis: correlation of serum levels of the nephritic factor with C3 levels, with therapy, and with progression of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Serum C'3 lytic system in patients with glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Classical complement pathway activation in membranoproliferative glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Serum immune complexes in membranoproliferative and other glomerulonephritides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

The morphogenesis of glomerular crescents in rapidly progressive glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Rapidly progressive (nonstreptococcal) glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Acute glomerulonephritis with prolonged oliguria. An analysis of 29 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

The long-term course of poststreptococcal glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Poststreptococcal glomerulonephritis. A prospective study in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Hypocomplementemic and normocomplementemic acute nephritis in children: a comparison with respect to etiology, clinical manifestations, and glomerular morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

TREATMENT OF OLIGURIC GLOMERULONEPHRITIS WITH DIALYSIS AND STEROIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Coagulation and renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Diffuse familial nephropathy: A clinicopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

A follow-up study of hereditary chronic nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

Familial hereditary nephropathy (Alport's syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

“Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980489-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(78)80489-2

1 reference

1 December 2017

1 reference